You have read all your free articles, to continue reading subscribe to read the rest of this content.
Immunicum has announced to transfer its patent rights for modified adenovirus (patent US 9,017,672 B2) to Elicera Therapeutics. The patent is currently out-licensed to Elicera and covers a modified adenovirus that improves gene delivery and tumor cell killing efficiency. “We are happy to enaAlready a subscriber Login You have read…
Vironova signs one-year agreement with the U.S. Food and Drug Administration to beta test proprietary Vironova Analyzing Software (VAS). In one of the fastest growing drug development areas today, nano-particles (for example liposomes), visible using electron microscopy, are used to deliver drugsAlready a subscriber Login You have read all your…
Acarix applies for entry on Nasdaq First North Premier in Stockholm. The capital contribution which the company pertain to obtain in connection to the entry is worth 140 million SEK, already secured through description and garantee undertakings. The capital from the entry will mainly go to the coAlready a subscriber…
BC Platforms has signed a partnership with Codigo46, an emerging Mexican company, focused on building and managing the largest biobank in Latin-America in co-operation with Mexican health and research specialists to deliver clinical patient benefits and future personalised medicines through academicAlready a subscriber Login You have read all your free…
